For Purchasing Managers, Technical Directors & Operations Leaders who need a reliable, cost‑effective supply of the premier HIV‑fusion‑inhibitor peptide.
Get Free Sample in 24 hIn 2025, the global market for HIV‑fusion‑inhibitor therapies grew by **12 %**, yet more than 40 % of manufacturers reported production delays caused by unreliable API sources. The following pain points are the most common blockers for B2B buyers like you:
Typical bulk Enfuvirtide pricing in the U.S. market exceeds $1,800 per gram, driven by limited suppliers and opaque pricing structures. The inflated cost erodes profit margins and makes large‑scale clinical trials financially untenable.
Regulatory filings demand ≥ 95 % purity (HPLC) and ≤ 5 ppm residual solvents. Many suppliers provide certificates that lack independent verification, leading to batch failures and costly re‑runs.
Standard lead times range from **45‑90 days**, with frequent customs holds. For a fast‑moving R&D pipeline, every extra day translates into delayed IND submissions and lost market advantage.
Missing or outdated DMF, GMP, and FDA‑accepted analytical reports force you to request supplementary data, extending the procurement cycle by up to **3 weeks**.
What if you could eliminate these four blockers in a single contract? The solution lies in a partner that couples **price transparency**, **certified quality**, **rapid delivery**, and **full regulatory compliance**.
Discover the Solution| Parameter | Specification | Test Method |
|---|---|---|
| Chemical Name | Enfuvirtide Acetate | N/A |
| Molecular Weight | 4495.8 g·mol⁻¹ | MALDI‑TOF |
| Purity (HPLC) | ≥ 98.5 % (single peak) | Validated RP‑HPLC |
| Residual Solvents | ≤ 5 ppm (ICH Q3C) | GC‑MS |
| Water Content | ≤ 0.5 % (Karl Fischer) | KF Titration |
| Stability | ≥ 24 months @ ‑20 °C (dry, sealed) | Real‑time & Accelerated |
| Packaging | HDPE 25 kg drum, 10 g amber vials, bulk bag (poly‑propylene) | N/A |
| Certificates | FDA DMF, EU CMA, GMP, ISO 9001, ISO 13485, CE, RoHS | N/A |
Our bulk Enfuvirtide acetate has been integrated into three distinct production pipelines:
Antiviral-screening-reagent-supplier Analgesic-research-peptide-analgesic-agent-manufacturer Arginine-Vasopressin-(AVP)-agonist Bacterial-cell-wall-inhibitor
“The price advantage was immediate – we saved $250 k on a 10 kg order. The purity data matched the certificate, so we avoided a costly batch failure.”
— Dr. Laura Chen, Procurement Lead, ViroGen Pharma
“30‑day delivery turned our IND filing timeline around. The API arrived on schedule, fully compliant with FDA DMF requirements.”
— Mark Rivera, Technical Director, NorthStar Biologics
Our standard MOQ is **100 g** for research‑grade material. For commercial production, we accept orders from **1 kg** up to **10 tons** with tiered pricing.
Yes. Our R&D team can tailor peptide length, N‑terminal modifications, and salt forms (acetate, chloride, etc.). Turn‑around for custom design is **15‑30 days** after specification approval.
We offer DDP (Delivered Duty Paid) to the U.S., EU, and Canada, with pre‑cleared HS codes. Typical freight from Zhengzhou to Los Angeles is **$1.2 /kg** via air, **$0.35 /kg** via sea. All shipments are accompanied by a full set of regulatory documents.

Standard terms: **30 % T/T in advance, 70 % upon shipment (L/C at sight accepted).** For trusted partners, we can extend to **Net 60** after the first three successful deliveries.
Stability studies show **≥ 24 months** at ‑20 °C (dry, sealed). At 4 °C, the peptide remains ≥ 95 % pure for **12 months**. We provide a Certificate of Analysis with each batch.
Our after‑sales team includes a dedicated peptide chemist who can assist with formulation, scale‑up, and regulatory filing. Support is available via email, WhatsApp, or video conference.
Free 100 mg samples are dispatched **within 24 h** after request confirmation, with express courier tracking.
All production runs for clinical supply are performed in our **cGMP‑certified** line, with batch records, validation reports, and full traceability provided to the buyer.
Get Your Personalized Quote NowOnly 5 tons of high‑purity Enfuvirtide acetate are allocated for the 2026 promotional batch. Order within the next 7 days to lock in the 30 % discount and receive a **free 100 mg sample** plus a **money‑back guarantee** if the API does not meet the stated specifications.
Emily Wu (Senior Procurement, HealthBridge Inc.) – “The **speed** of delivery and the **transparent pricing** allowed us to keep our Phase II budget on track. The API’s purity was spot‑on, and the documentation saved us two weeks of FDA correspondence.”
Dr. Ahmed El‑Sayed (Head of R&D, Medica Labs) – “We needed a **custom acetate salt** for a novel formulation. Global Technology delivered the exact specification within 18 days, and the stability data matched our expectations. Highly recommended for OEM projects.”
James Patel (Operations Manager, BioNova Therapeutics) – “The **free sample** arrived in 24 hours, and the batch analysis was flawless. Our finance team loved the **30 % cost reduction**, and the after‑sales support resolved a minor packaging issue within hours.”
Dr. Li Cheng – Senior Peptide Chemist & Global Business Development Lead at Global Technology Co., Ltd. With **15 years** in peptide API manufacturing, Dr. Cheng has overseen the scale‑up of more than **30 FDA‑approved peptide drugs**, authored **8 peer‑reviewed papers**, and holds a **Ph.D. in Pharmaceutical Sciences** from Zhejiang University. He regularly advises multinational pharma on GMP compliance and cost‑optimization strategies.
Contact: service@huanqiukeji9.com | Tel: +86 199 4383 0844
Global Technology Co., Ltd | No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China
Phone: +86 199 4383 0844 | Email: service@huanqiukeji9.com
Visit our Contact Page for more details, privacy policy, and legal notices.